×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by Charles S. Berkman

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
OABIOmniAb, Inc.Charles S. BerkmanChief Legal OfficerDec 07, 2025Option/RSU Exercise-15,621-385,115Dec 09, 2025, 09:02 AM
OABIOmniAb, Inc.Charles S. BerkmanChief Legal OfficerDec 08, 2025Sale$1.968,04415,766377,071Dec 09, 2025, 09:02 AM
OABIOmniAb, Inc.Charles S. BerkmanChief Legal OfficerApr 07, 2025Option/RSU Exercise-13,542-370,418Apr 07, 2025, 08:10 PM
OABIOmniAb, Inc.Charles S. BerkmanChief Legal OfficerApr 07, 2025Sale$2.007,20614,412363,212Apr 07, 2025, 08:10 PM
OABIOmniAb, Inc.Charles S. BerkmanChief Legal OfficerFeb 19, 2025Sale$3.677,25526,626356,876Feb 19, 2025, 08:50 PM
OABIOmniAb, Inc.Charles S. BerkmanChief Legal OfficerFeb 15, 2025Option/RSU Exercise-15,615-358,805Feb 19, 2025, 08:50 PM
OABIOmniAb, Inc.Charles S. BerkmanChief Legal OfficerFeb 16, 2025Option/RSU Exercise-13,541-372,346Feb 19, 2025, 08:50 PM
OABIOmniAb, Inc.Charles S. BerkmanChief Legal OfficerFeb 18, 2025Sale$3.688,21530,231364,131Feb 19, 2025, 08:50 PM
OABIOmniAb, Inc.Charles S. BerkmanChief Legal OfficerJan 21, 2025Sale$3.2425,48982,584343,190Jan 22, 2025, 05:41 PM
OABIOmniAb, Inc.Charles S. BerkmanChief Legal OfficerDec 09, 2024Sale$4.138,02233,131323,385Dec 10, 2024, 04:47 PM
OABIOmniAb, Inc.Charles S. BerkmanChief Legal OfficerDec 07, 2024Option/RSU Exercise-15,621-331,407Dec 10, 2024, 04:47 PM
OABIOmniAb, Inc.Charles S. BerkmanChief Legal OfficerApr 07, 2024Option/RSU Exercise-13,541-299,571Apr 09, 2024, 06:37 PM
OABIOmniAb, Inc.Charles S. BerkmanChief Legal OfficerApr 08, 2024Sale$5.276,95436,648292,617Apr 09, 2024, 06:37 PM
OABIOmniAb, Inc.Charles S. BerkmanChief Legal OfficerFeb 15, 2024Tax Payment (Shares)$5.547,60942,154286,030Feb 20, 2024, 06:22 PM
OABIOmniAb, Inc.Charles S. BerkmanChief Legal OfficerFeb 15, 2024Option/RSU Exercise-21,322-288,064Feb 20, 2024, 06:22 PM
OABIOmniAb, Inc.Charles S. BerkmanChief Legal OfficerJan 02, 2024Tax Payment (Shares)$6.257,19544,969272,317Jan 03, 2024, 05:42 PM
OABIOmniAb, Inc.Charles S. BerkmanChief Legal OfficerJan 02, 2024Option/RSU Exercise-17,556-279,512Jan 03, 2024, 05:42 PM
OABIOmniAb, Inc.Charles S. BerkmanChief Legal OfficerDec 07, 2023Tax Payment (Shares)$4.855,40326,205261,956Dec 11, 2023, 07:21 PM
OABIOmniAb, Inc.Charles S. BerkmanChief Legal OfficerDec 07, 2023Option/RSU Exercise-15,622-267,359Dec 11, 2023, 07:21 PM
OABIOmniAb, Inc.Charles S. BerkmanChief Legal OfficerFeb 15, 2023Tax Payment (Shares)$3.809,54336,263381,509Feb 17, 2023, 07:50 PM
OABIOmniAb, Inc.Charles S. BerkmanSee RemarksDec 28, 2022Tax Payment (Shares)$3.666,51823,856336,618Dec 30, 2022, 05:00 PM
OABIOmniAb, Inc.Charles S. BerkmanSee RemarksDec 01, 2022Tax Payment (Shares)$3.3510,58035,443343,136Dec 05, 2022, 09:41 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanSVP, Gen. Counsel & SecretaryJan 26, 2022Tax Payment (Shares)$113.682,156245,09433,298Jan 28, 2022, 08:42 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanSVP, Gen. Counsel & SecretaryFeb 15, 2021Tax Payment (Shares)$172.461,015175,04728,701Feb 18, 2021, 06:28 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanSVP, Gen. Counsel & SecretaryFeb 04, 2021Sale$178.5018,0973,230,36928,906Feb 05, 2021, 05:03 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanSVP, Gen. Counsel & SecretaryJan 25, 2021Tax Payment (Shares)$156.041,339208,94343,512Jan 27, 2021, 07:02 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanSVP, Gen. Counsel & SecretaryJun 30, 2020Other Acquisition or Disposition$89.0323821,18941,115Jul 01, 2020, 08:06 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanSVP, Gen. Counsel & SecretaryJun 04, 2020Sale$118.5911,1461,321,77140,877Jun 05, 2020, 04:07 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanSVP, Gen. Counsel & SecretaryFeb 15, 2020Tax Payment (Shares)$97.2388185,66052,597Feb 18, 2020, 05:07 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanSVP, Gen. Counsel & SecretaryDec 20, 2019Tax Payment (Shares)$105.871,131119,73949,069Dec 26, 2019, 02:01 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanSVP, Gen. Counsel & SecretaryAug 05, 2019Option/RSU Exercise$67.721,09374,01347,172Aug 06, 2019, 05:17 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanSVP, Gen. Counsel & SecretaryJun 28, 2019Other Acquisition or Disposition$97.0318217,65946,079Jul 02, 2019, 09:50 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanSVP, Gen. Counsel & SecretaryJan 10, 2019Option/RSU Exercise$65.622,850187,02939,913Jan 14, 2019, 09:17 AM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanSVP, Gen. Counsel & SecretaryDec 17, 2018Option/RSU Exercise$21.923,40074,52837,063Dec 17, 2018, 07:58 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanSVP, Gen. Counsel & SecretaryOct 24, 2018Option/RSU Exercise$16.793,90065,46233,663Oct 25, 2018, 05:44 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanSVP, Gen. Counsel & SecretaryOct 11, 2018Option/RSU Exercise$14.472,00028,94029,763Oct 12, 2018, 06:52 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanSVP, Gen. Counsel & SecretarySep 17, 2018Option/RSU Exercise$100.382,813282,36930,576Sep 18, 2018, 06:16 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanSVP, Gen. Counsel & SecretarySep 17, 2018Sale$250.692,813705,18327,763Sep 18, 2018, 06:16 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanSVP, Gen. Counsel & SecretarySep 04, 2018Option/RSU Exercise$69.9819,4171,358,79647,180Sep 05, 2018, 08:00 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanSVP, Gen. Counsel & SecretarySep 04, 2018Sale$254.9919,4174,951,06327,763Sep 05, 2018, 08:00 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanSVP, Gen. Counsel & SecretaryJun 29, 2018Other Acquisition or Disposition$117.8418021,21027,763Jul 03, 2018, 03:27 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanSVP, Gen. Counsel & SecretaryMar 06, 2018Tax Payment (Shares)$165.8739265,02127,583Mar 06, 2018, 06:36 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanSVP, Gen. Counsel & SecretaryFeb 15, 2018Tax Payment (Shares)$157.181,036162,83825,571Feb 16, 2018, 05:40 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryDec 28, 2017Tax Payment (Shares)$138.661,175162,92626,095Dec 29, 2017, 09:16 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryAug 09, 2017Sale$126.9618,6252,364,66724,423Aug 10, 2017, 06:40 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryJun 30, 2017Other Acquisition or Disposition$87.1324321,17143,048Jul 05, 2017, 06:45 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryAug 05, 2016Sale$123.1622,0672,717,77229,647Aug 09, 2016, 04:58 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryAug 05, 2016Option/RSU Exercise$54.7630,3471,661,85741,731Aug 09, 2016, 04:58 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryJul 10, 2015Option/RSU Exercise$12.7014,067178,68740,521Jul 14, 2015, 07:35 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryJul 10, 2015Sale$99.1414,0671,394,61038,117Jul 14, 2015, 07:35 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryJul 13, 2015Option/RSU Exercise$53.101,00053,10027,454Jul 14, 2015, 07:35 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryJun 30, 2015Other Acquisition or Disposition$45.6746521,23726,454Jul 01, 2015, 12:36 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryMar 16, 2015Option/RSU Exercise$20.325,264106,93930,119Mar 18, 2015, 04:32 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryMar 16, 2015Sale$74.5411,264839,64925,989Mar 18, 2015, 04:32 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryDec 31, 2014Other Acquisition or Disposition$45.231265,69927,433Mar 18, 2015, 04:28 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryDec 31, 2014Buy$45.231265,69927,433Jan 05, 2015, 07:47 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryJun 30, 2014Buy$43.7932914,40827,307Jul 01, 2014, 12:16 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryMay 27, 2014Option/RSU Exercise$18.812,49947,00728,644May 28, 2014, 06:03 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryMay 27, 2014Sale$66.907,166479,43426,978May 28, 2014, 06:03 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryFeb 12, 2014Option/RSU Exercise$16.1814,881240,78434,424Feb 14, 2014, 08:06 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryFeb 12, 2014Sale$74.5014,8811,108,63529,645Feb 14, 2014, 08:06 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryFeb 13, 2014Option/RSU Exercise$14.472,00028,94031,645Feb 14, 2014, 08:06 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryDec 31, 2013Buy$33.922097,08827,145Jan 02, 2014, 04:48 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryAug 30, 2013Option/RSU Exercise$17.5137,331653,69729,732Sep 04, 2013, 07:10 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryAug 30, 2013Sale$47.5428,3231,346,45617,928Sep 04, 2013, 07:10 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryAug 16, 2013Option/RSU Exercise$9.9614,583145,24728,227Aug 20, 2013, 06:44 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryAug 16, 2013Sale$42.6314,583621,73213,644Aug 20, 2013, 06:44 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryAug 19, 2013Option/RSU Exercise$10.054,28443,05417,928Aug 20, 2013, 06:44 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryJun 28, 2013Buy$17.3681514,14813,644Jul 01, 2013, 03:26 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryMay 10, 2013Sale$26.664,000106,64012,829May 13, 2013, 06:46 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretarySep 07, 2012Sale$18.774,24979,75414,329Sep 10, 2012, 01:55 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryJun 29, 2012Other Acquisition or Disposition$10.121,25012,65418,578Jul 03, 2012, 05:46 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryMar 08, 2012Sale$15.763,60656,83217,434Mar 08, 2012, 06:24 PM
LGNDDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryDec 30, 2011Other Acquisition or Disposition$10.091,23812,49115,934Jan 06, 2012, 05:19 PM
LGNDLIGAND PHARMACEUTICALS INCCharles S. BerkmanVP, Gen. Counsel & SecretaryFeb 16, 2011Sale$9.755,00048,75111,696Feb 18, 2011, 05:38 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe